Active Ingredient(s):Treprostinil Sodium FDA Approved: * July 30, 2009 Pharm Company: *UNITED THERAP Category:Blood Pressure
Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
Treprostinil was approved for use in the United States in May 2002.
The drug can be given in various forms: IV, subcutaneous injection, oral inhalation, as well as oral extended-release tablets. The subc...
* May have multiple approval dates, manufacturers, or labelers. 7 Discussions